Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04234724 · ClinicalTrials.gov registry record · NA
Physiological Effects of ANGPTL3 Variants in Humans
A NA study of Hypocholesterolemia, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04234724 is a NA study of Hypocholesterolemia that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04234724, a NA study of Hypocholesterolemia, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the role of ANGPTL3, on lipid metabolism. To explore the role of this protein on glucose metabolism.
Conditions Studied
Interventions
- OTHER Kinetics test, oral fat tolerance test, and an oral glucose tolerance test.
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04234724
The ClinicalTrials.gov registry entry for NCT04234724 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypocholesterolemia appearing as the primary indexed condition, and to 1 intervention - of which Kinetics test, oral fat tolerance test, and an oral glucose tolerance test. is the first listed.
NCT04234724 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04234724 about?
NCT04234724 is a clinical study titled "Physiological Effects of ANGPTL3 Variants in Humans". To evaluate the role of ANGPTL3, on lipid metabolism. To explore the role of this protein on glucose metabolism.
What is the current status of trial NCT04234724?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2020-12-01. Estimated completion is 2026-06-30.
What conditions does trial NCT04234724 study?
This clinical trial studies the following conditions: Hypocholesterolemia.
What interventions are being tested in trial NCT04234724?
The interventions under investigation include: Kinetics test, oral fat tolerance test, and an oral glucose tolerance test. (OTHER).
Who is sponsoring clinical trial NCT04234724?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04234724 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.